Delaying Noncardiac Surgery for Several Months After Heart Attack Found to Be Safer
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 14, 2024 -- Delaying noncardiac surgeries for three to six months following a heart attack appears safer for those who undergo revascularization, according to a study published online Oct. 30 in JAMA Surgery.
Laurent G. Glance, M.D., from the University of Rochester in New York, and colleagues examined the association between the time since a non-ST-segment elevation myocardial infarction (NSTEMI) and the risk for postoperative major adverse cardiovascular and cerebrovascular events (MACCE). The analysis included Medicare claims data (2015 to 2020) for patients 67 years or older who had major noncardiac surgery (roughly 5.2 million surgeries).
The researchers found that compared with patients without a prior NSTEMI, patients with an NSTEMI within 30 days of elective surgery had higher odds of MACCE, regardless of whether they had undergone coronary revascularization (adjusted odds ratio [aOR], 2.15) or not (aOR, 2.04). After 30 days, the odds of postoperative MACCE leveled off in patients who had undergone any coronary revascularization procedure (and after 90 days in patients with drug-eluting stents). However, there was an increase after 180 days (any revascularization at 181 to 365 days: aOR, 1.46; patients with drug-eluting stents at 181 to 365 days: aOR, 1.73). For those not undergoing revascularization, the odds of MACCE did not level off. Findings were similar for all-cause 30-day mortality, except that the odds of mortality in patients with previous NSTEMI who had revascularization leveled off after 60 days in elective surgeries and 90 days for nonelective surgeries.
"Delaying elective noncardiac surgery to occur between 90 and 180 days after an NSTEMI may be reasonable for patients who have had revascularization," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-15 06:00
Read more
- Stroke Survivors Face Much Higher Odds for Dementia
- Preferential Promotion of White Men Persisting in Academic Medicine
- Newer Drug Could Be Advance Against Tough-to-Treat Breast Cancers
- Sleep-Disordered Breathing Linked to Larger Hippocampal Volume
- CORSWO Model Stratifies Women According to Coronary Risk
- FDA Approves Ryoncil (remestemcel-L-rknd) Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft Versus Host Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions